Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Ongoing Initiated Mar 12, 2017 (10 years ago)

EpiPen Jr. 2-Pak (Epinephrine)

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

Cause type: Packaging defect

Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.

What was recalled

EpiPen Jr. 2-Pak (Epinephrine) Auto-Injectors 0.15 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- ALSO LABELED OUTSIDE THE US AS: Epipen Auto-Injector Jr. 0.15 mg -Bright Stock labeled for multiple countries- manufactured for Mylan by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company.

Affected NDC 49502-0500-02

Compare with the code on your package — it is the most precise check available.

Drug: Epinephrine

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Epipen
epinephrine
NDC 49502-0500
.3 mg/.3mL Injection
Intramuscular
Viatris Specialty LLC Rx
Recalling firm
Meridian Medical Technologies a Pfizer Company
NDC code
49502-500-02
Origin
MO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0691-2017 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week.

Other Epinephrine recalls

See all
Class I · High risk

Epinephrine Injection

Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.

Ongoing Sterility / contamination American Regent, Inc. NDC 0517-3030-01 D-0865-2026
Class II · Moderate risk

Maximum

Stability Data Does Not Support Expiry Date.

Ongoing Stability / shelf life HTO Nevada Inc. dba Kirkman D-0387-2026

Other recalls by Meridian Medical Technologies a Pfizer Company

All 2017 recalls
Class I · High risk

EpiPen 2-Pak

Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

Ongoing Packaging defect Meridian Medical Technologies a Pfizer Company NDC 49502-500-02 D-0690-2017
Class II · Moderate risk

Diazepam Injection

Impurities/Degradation Products: High Out of Specification levels for carbostyril, a known degradation product of diazepam.

Terminated Impurity / degradation Meridian Medical Technologies a Pfizer Company NDC 11704-600-01 D-1369-2012